Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 3/20 | 0.64 |
| ▸ | PAOX | Q6QHF9 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.52 |
| ▸ | RECQL | P46063 | 2/20 | 0.52 |
| ▸ | MEN1 | O00255 | 1/20 | 0.52 |
| ▸ | PLG | P00747 | 1/20 | 0.52 |
| ▸ | THRB | P10828 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.48 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.48 |
| ▸ | BLM | P54132 | 1/20 | 0.46 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1147174 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL7545025 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL1235539 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL1701715 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL3208419 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL2822938 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL7541388 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL7548607 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL2128896 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A | |
| SCHEMBL905418 | 1.00 | TSHR (0.64) | TSHRPAOXLMNAALDH1A1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20250019731-A1 | Methods Of Producing Omega-Hydroxylated Fatty Acid Derivatives | AGAIN BIO APS (DK) | 2025-01-16 | — | — | US | disclosed |
| US-11981952-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2024-05-14 | — | — | US | disclosed |
| US-11912997-B2 | RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use | Arrowhead Pharmaceuticals, Inc. (US) | 2024-02-27 | — | — | US | disclosed |
| US-20210071212-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | GENOMATICA, INC. (US) | 2021-03-11 | — | — | US | disclosed |
| EP-3745133-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | Genomatica, Inc. (US) | 2020-12-02 | — | — | EP | disclosed |
| US-10711288-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | GENOMATICA, INC. (US) | 2020-07-14 | — | — | US | disclosed |
| EP-3673921-A1 | MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN | Baxalta GmbH (CH) | 2020-07-01 | — | — | EP | disclosed |
| EP-2984490-B1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | GENOMATICA INC (US) | 2020-05-20 | — | — | EP | disclosed |
| EP-2654794-B1 | MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN | Baxalta GmbH (CH) | 2020-03-04 | — | — | EP | disclosed |
| EP-2984490-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | REG Life Sciences, LLC (US) | 2016-02-17 | — | — | EP | disclosed |
| US-8945897-B2 | Materials and methods for conjugating a water soluble fatty acid derivative to a protein | BAXTER INTERNATIONAL INC. (US) | 2015-02-03 | — | — | US | disclosed |
| WO-2014201474-A1 | METHODS OF PRODUCING OMEGA-HYDROXYLATED FATTY ACID DERIVATIVES | LS9, INC. (US) | 2014-12-18 | — | — | WO | disclosed |
| EP-2654794-A1 | MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN | Baxter International Inc (US) | 2013-10-30 | — | — | EP | disclosed |
| US-20120190096-A1 | MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN | BAXTER HEALTHCARE S.A. (CH) | 2012-07-26 | — | — | US | disclosed |
| WO-2012087838-A1 | MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN | BAXTER INTERNATIONAL INC. (US) | 2012-06-28 | — | — | WO | disclosed |
| EP-0885886-B1 | PYRIDINECARBOXAMIDE DERIVATIVES | NISSHIN SEIFUN GROUP INC (JP) | 2002-05-29 | — | — | EP | disclosed |
| US-5972943-A | N-(NITRIC ACID,C14-18 ALKYL ESTER)-6-(1-(OPTIONALLY 4-SUBSTITUTED PIPERAZINYL)) PYRIDINE-3-CARBOXAMIDES; METHOD OF SYNTHESIS; ADMINISTERING TO TREAT CEREBRAL EDEMA; NO HYPOTENSIVE SIDE EFFECT | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1999-10-26 | — | — | US | disclosed |
| EP-0885886-A1 | NOVEL PYRIDINECARBOXAMIDE DERIVATIVES | Nisshin Flour Milling Co., Ltd. (JP) | 1998-12-23 | — | — | EP | disclosed |
| US-5468888-A | Lupane derivatives, their preparation and the pharmaceutical compositions which contain them | RHONE-POULENC RORER S.A. (FR) | 1995-11-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11912997-B2 | RNAi agents for inhibiting expression of Superoxide Dismutase 1 (SOD1), compositions thereof, and methods of use | SOD1, SOD3, SMN1; SMN2 | TSHR 4636/4885PAOX 2489/4885LMNA 2101/4885 |
| US-12595495-B2 | Methods of producing omega-hydroxylated fatty acid derivatives | CYP4F11, CYP2F1, CYP4Z1 | TSHR 1330/4885PAOX 684/4885LMNA 3439/4885 |
| US-20120190096-A1 | MATERIALS AND METHODS FOR CONJUGATING A WATER SOLUBLE FATTY ACID DERIVATIVE TO A PROTEIN | FABP1, FABP4, FABP5 | TSHR 3304/4885PAOX 498/4885LMNA 2670/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.